Leishmaniasis Clinical Trials

• Surveillance for Leishmaniasis Skin Lesions in Mali
  ClinicalTrials.gov Identifier: NCT00344084 - Active, not recruiting
  Cutaneous Leishmaniasis
  
• Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00373568 - Active, not recruiting
  Leishmaniasis
  
• Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00317980 - Active, not recruiting
  Cutaneous Leishmaniasis
  
• A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.
  ClinicalTrials.gov Identifier: NCT00381394 - Active, not recruiting
  Visceral Leishmaniasis
  
• Expression of Mif Alleles in Individuals With Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00401349 - Recruiting
  Leishmaniasis
  
• Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia
  ClinicalTrials.gov Identifier: NCT00233545 - Active, not recruiting
  Cutaneous Leishmaniasis
  
• Clinical Investigation of Infections Due to Leishmanial Parasites
  ClinicalTrials.gov Identifier: NCT00001169 - Completed
  Leishmaniasis; Leishmaniasis, Visceral
  
• Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India
  ClinicalTrials.gov Identifier: NCT00486382 - Recruiting
  Visceral Leishmaniasis; Post-Kala-Azar Dermal Leishmaniasis
  
• Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00317629 - Recruiting
  Cutaneous Leishmaniasis
  
• Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00469495 - Recruiting
  Leishmaniasis, Cutaneous; Helminthiasis
  
• Evaluation of Efficacy and Safety of Miltefosine for Cutaneous Leishmaniasis in Colombia
  ClinicalTrials.gov Identifier: NCT00471705 - Recruiting
  Cutaneous Leishmaniasis
  
• Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
  ClinicalTrials.gov Identifier: NCT00487253 - Recruiting
  Cutaneous Leishmaniasis
  
• Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00255567 - Recruiting
  Visceral Leishmaniasis
  
• Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00257530 - Not yet recruiting
  Cutaneous Leishmaniasis
  
• Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
  ClinicalTrials.gov Identifier: NCT00001906 - Completed
  Cutaneous Leishmaniasis
  
• Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application
  ClinicalTrials.gov Identifier: NCT00490230 - Not yet recruiting
  Cutaneous Leishmaniasis; Scar
  
• Combination Therapy in Indian Visceral Leishmaniasis - Phase IIb
  ClinicalTrials.gov Identifier: NCT00523965 - Not yet recruiting
  Leishmaniasis, Visceral
  
• Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
  ClinicalTrials.gov Identifier: NCT00480883 - Recruiting
  Leishmaniasis, Cutaneous
  
• Immunogenetics of Visceral Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00342823 - Recruiting
  Visceral Leishmaniasis
  
• Miltefosine for Mucosal Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00373776 - Completed
  Leishmaniasis
  
• Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil
  ClinicalTrials.gov Identifier: NCT00004755 - Completed
  Leishmaniasis
  
• Diagnosis and Treatment of Leishmanial Infections
  ClinicalTrials.gov Identifier: NCT00344188 - Recruiting
  Leishmaniasis
  
• Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00216346 - Completed
  Visceral Leishmaniasis
  
• Miltefosine for Brazilian Visceral Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00378495 - Recruiting
  Kala Azar
  
• Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite.
  ClinicalTrials.gov Identifier: NCT00121849 - Completed
  Cutaneous Leishmaniasis
  
• Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes
  ClinicalTrials.gov Identifier: NCT00401297 - Recruiting
  Leishmaniasis
  
• Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection
  ClinicalTrials.gov Identifier: NCT00401557 - Recruiting
  Leishmaniasis
  
• Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00111514 - Completed
  Leishmaniasis, Mucocutaneous
  
• Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
  ClinicalTrials.gov Identifier: NCT00537953 - Recruiting
  Cutaneous Leihmaniasis
  
• Amphotericin B Treatment in Visceral Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00310505 - Completed
  Visceral Leishmaniasis
  
• Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00111553 - Completed
  Leishmaniasis, Cutaneous
  
• Short Course of Miltefosine and Liposomal Amphotericin B for Kala-Azar
  ClinicalTrials.gov Identifier: NCT00371995 - Not yet recruiting
  Visceral Leishmaniasis
  
• Efficacy, Acceptability and Cost-Effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar
  ClinicalTrials.gov Identifier: NCT00318721 - Recruiting
  Visceral Leishmaniasis; Kala Azar
  
• Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite
  ClinicalTrials.gov Identifier: NCT00121862 - Completed
  Cutaneous Leishmaniasis
  
• Combination Chemotherapy for the Treatment of Indian Kala-Azar
  ClinicalTrials.gov Identifier: NCT00370825 - Completed
  Visceral Leishmaniasis
  
• Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica
  ClinicalTrials.gov Identifier: NCT00351520 - Completed
  Cutaneous Leishmaniasis
  
• A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar
  ClinicalTrials.gov Identifier: NCT00497601 - Completed
  Visceral Leishmaniasis